HLOSF
Price
$3.40
Change
-$0.23 (-6.34%)
Updated
Oct 31 closing price
Capitalization
336.66M
Intraday BUY SELL Signals
LGVN
Price
$0.61
Change
-$0.03 (-4.69%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
13.65M
Intraday BUY SELL Signals
Interact to see
Advertisement

HLOSF vs LGVN

Header iconHLOSF vs LGVN Comparison
Open Charts HLOSF vs LGVNBanner chart's image
HEALIOS K K
Price$3.40
Change-$0.23 (-6.34%)
Volume$8.15K
Capitalization336.66M
Longeveron
Price$0.61
Change-$0.03 (-4.69%)
Volume$100
Capitalization13.65M
HLOSF vs LGVN Comparison Chart in %
HLOSF
Daily Signal:
Gain/Loss:
LGVN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HLOSF vs. LGVN commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLOSF is a Hold and LGVN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (HLOSF: $3.40 vs. LGVN: $0.64)
Brand notoriety: HLOSF and LGVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HLOSF: 19% vs. LGVN: 56%
Market capitalization -- HLOSF: $335.94M vs. LGVN: $13.11M
HLOSF [@Biotechnology] is valued at $335.94M. LGVN’s [@Biotechnology] market capitalization is $13.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLOSF’s FA Score shows that 0 FA rating(s) are green whileLGVN’s FA Score has 0 green FA rating(s).

  • HLOSF’s FA Score: 0 green, 5 red.
  • LGVN’s FA Score: 0 green, 5 red.
According to our system of comparison, LGVN is a better buy in the long-term than HLOSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLOSF’s TA Score shows that 5 TA indicator(s) are bullish while LGVN’s TA Score has 3 bullish TA indicator(s).

  • HLOSF’s TA Score: 5 bullish, 1 bearish.
  • LGVN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, HLOSF is a better buy in the short-term than LGVN.

Price Growth

HLOSF (@Biotechnology) experienced а 0.00% price change this week, while LGVN (@Biotechnology) price change was -10.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLOSF($337M) has a higher market cap than LGVN($13.7M). HLOSF YTD gains are higher at: 151.852 vs. LGVN (-63.006). LGVN has higher annual earnings (EBITDA): -18.35M vs. HLOSF (-2.39B). HLOSF has more cash in the bank: 6.25B vs. LGVN (10.3M). LGVN has less debt than HLOSF: LGVN (1.14M) vs HLOSF (2.61B). HLOSF has higher revenues than LGVN: HLOSF (112M) vs LGVN (2.07M).
HLOSFLGVNHLOSF / LGVN
Capitalization337M13.7M2,460%
EBITDA-2.39B-18.35M13,036%
Gain YTD151.852-63.006-241%
P/E RatioN/A2.95-
Revenue112M2.07M5,403%
Total Cash6.25B10.3M60,631%
Total Debt2.61B1.14M228,509%
TECHNICAL ANALYSIS
Technical Analysis
HLOSFLGVN
RSI
ODDS (%)
Bullish Trend 2 days ago
40%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
28%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
42%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
15%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
28%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 27 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
20%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HLOSF
Daily Signal:
Gain/Loss:
LGVN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FCAP45.730.73
+1.62%
First Capital
VINP12.030.10
+0.84%
Vinci Compass Investments Ltd
GLBZ4.490.02
+0.45%
Glen Burnie Bancorp
VOD12.250.04
+0.33%
Vodafone Group Plc
PVH73.67-2.41
-3.17%
PVH Corp

HLOSF and

Correlation & Price change

A.I.dvisor tells us that HLOSF and BRTX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLOSF and BRTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLOSF
1D Price
Change %
HLOSF100%
N/A
BRTX - HLOSF
23%
Poorly correlated
N/A
LGVN - HLOSF
22%
Poorly correlated
-1.39%
ENTBF - HLOSF
7%
Poorly correlated
N/A
CPMV - HLOSF
5%
Poorly correlated
N/A
SLN - HLOSF
3%
Poorly correlated
+0.30%
More

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with BIVI. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then BIVI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
-1.39%
BIVI - LGVN
50%
Loosely correlated
+0.71%
RXRX - LGVN
40%
Loosely correlated
+0.97%
QURE - LGVN
37%
Loosely correlated
-2.14%
HRTX - LGVN
37%
Loosely correlated
+2.75%
SNGX - LGVN
36%
Loosely correlated
+2.59%
More